Indication
Osteomyelitis
12 clinical trials
19 products
1 drug
Clinical trial
A Multi-center, Randomized (1:1), Controlled Phase II Trial of STIMULAN VG With Debridement and a Course of Systemic Antibiotics vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.Status: Not yet recruiting, Estimated PCD: 2024-12-01
Product
STIMULAN VGClinical trial
Phase 2b Randomized, Parallel, Double-blind, Placebo-Controlled, Repeat Dose, Multi-Site Study for Safety, Tolerability, and Efficacy of Personalized Phage Treatment and SoC for Subjects With Diabetic Foot Osteomyelitis Due to S. AureusStatus: Recruiting, Estimated PCD: 2024-04-01
Product
Phage TherapyClinical trial
Effect of Pulsed Electromagnetic Field Stimulation on Localized Pediatric Osteomyelitis : Randomized Control Trail StudyStatus: Recruiting, Estimated PCD: 2023-12-30
Product
AntibioticsClinical trial
Don't Treat Ghosts: Anti-MRSA Antibiotics in Osteomyelitis Without Identified MRSAStatus: Recruiting, Estimated PCD: 2024-06-23
Product
Anti-MRSA therapyClinical trial
Pilot Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRIStatus: Completed, Estimated PCD: 2014-07-01
Product
FerahemeClinical trial
Oral-only Antibiotics for Bone and Joint Infections in Children - A Nationwide Randomized Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2024-01-01
Product
Oral Co-amoxiclavProduct
IV ceftriaxonClinical trial
Oral Versus Intravenous Antibiotics for the Management of the Osteomyelitis of the Jaws: An Open-Label Non-Inferiority Single-Arm Clinical TrialStatus: Not yet recruiting, Estimated PCD: 2025-11-01
Product
Amoxicillin-clavulanateProduct
ClindamycinProduct
LevofloxacinClinical trial
Dalbavancin For The Treatment Of Gram Positive Osteomyelitis Or Joint Infections Including Prosthetic Hip Or Knee InfectionsStatus: Completed, Estimated PCD: 2022-12-31
Product
DalbavancinProduct
VancomycinClinical trial
Ferumoxytol Contrast for the MRI Imaging of OsteomyelitisStatus: Completed, Estimated PCD: 2019-08-12
Product
FerumoxidesClinical trial
BonE and Joint Infections - Simplifying Treatment in Children TrialStatus: Recruiting, Estimated PCD: 2026-12-01
Product
CefalexinClinical trial
Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk PatientsStatus: Terminated, Estimated PCD: 2012-09-01
Product
CeftarolineClinical trial
A Prospective, Randomized Trial Comparing Vancomycin With Trimethoprim/Sulfamethoxazole for the Treatment of MRSA OsteomyelitisStatus: Completed, Estimated PCD: 2007-05-01
Drug
vancomycinProduct
DaptomycinProduct
Linezolid